4
Changes in Ownership
MAIA Biotechnology, Inc. Filed Acc 0001127602-23-011737
Chief Executive Officer bought 1,700 shares at an average $3.46 ($5,876)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vitoc Vlad Chief Executive Officer | 2023-03-30 | Purchase 10b5-1 | +205 | $3.43 | $703 | 801,326 | D: show line 1 in the form |
| Vitoc Vlad Chief Executive Officer | 2023-03-31 | Purchase 10b5-1 | +1,495 | $3.46 | $5,173 | 802,821 | D: show line 2 in the form |
| Open-market purchases · 1,700 sh · avg $3.46 · $5,876 | |||||||
Loading xslF345X04/form4.xml…